Charlotte, North Carolina-based, Albemarle Corporation (ALB) develops, manufactures, and markets engineered specialty chemicals worldwide. With a market cap of $11.3 billion, Albemarle operates through Energy Storage, Specialties, and Ketjen segments. It is expected to announce its Q3 earnings after the market closes on Wednesday, Nov. 6.
Ahead of the event, analysts expect Albemarle to report a loss of $0.21 per share, down 107.7% from the profit of $2.74 per share reported in the year-ago quarter. The company has surpassed Wall Street's bottom-line estimates in one of the last four quarters while missing on three other occasions. Its adjusted EPS for the last reported quarter dipped 99.5% year-over-year to $0.04, missing the consensus estimates by 92.5%.
